BioSpace News Archive

On Monday, the House passed a bipartisan bill designed to reportedly boost scientific research and increase the scientific competitiveness of the U.S. to that of China.

Geneva, Switzerland, June 29, 2021 - Addex Therapeutics Ltd, a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced that screening of patients has started for its pivotal Phase 2b/3 study with dipraglurant for dyskinesia associated with Parkinson’s disease.

Norway Oncoinvent AS, a clinical stage company advancing a pipeline of radiopharmaceutical products across a variety of solid cancers, announced that the company has raised NOK 250 million in an oversubscribed pre-IPO financing round syndicated by existing investors Hadean Ventures, Geveran, RADFORSK Investeringsstiftelse, Sundt, Must Invest, Canica, MP Pensjon and Watrium.

RELIEF THERAPEUTICS Holding AG announced that it has signed and closed the definitive agreement to acquire all outstanding shares of APR Applied Pharma Research S.A., a privately held Swiss pharmaceutical company with over 25 years’ experience in identifying, developing and commercializing known molecules engineered with drug delivery systems in niche and rare diseases on a global basis.

Biological products or biologics refer to medicines manufactured using living organisms. For the manufacturing of these products, highly complex processes are performed under strict observations and controlled conditions.

The growth of the global immunofluorescence assay market is ascribed to the rising prevalence of various chronic illnesses.

Laudable advancements in the field of oncology have given a mark of credibility to the medical research fraternity.

Preoperative planning involves a rigorous analysis of implants and aids that are to be using during surgery.

POC devices or point of care devices are mainly used for medical diagnostic tests. These tests are conducted at a time and place convenient for patient care.

Aragen Life Sciences, a leading Contract Research and Development Organization, headquartered out of Hyderabad, India, announces an expansion of their discovery research agreement with Boehringer Ingelheim, with the goal of accelerating the discovery pipeline of Boehringer Ingelheim.